SiteOne Therapeutics

SiteOne Therapeutics is dedicated to developing novel pain medications that can safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing drugs, such as opioids. Given the critical role NaV1.7 plays in the generation and transmission of pain signals, coupled with the urgent need for new non-opioid pain therapies, SiteOne is committed to advancing its lead product to serve patients with moderate to severe pain.